Research at Duke University in genomics that involved fighting cancer by looking for gene patterns that would determine which drugs would best attack a particular cancer (no more trial-and-error treatment, considered a breakthrough). This research turned out to be wrong, due to flaws in the research (found by statisticians); if the research was reproducible, errors could have been found earlier and the patients could have continued their treatment.